AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
16 Feb 2017 //
PR NEWSWIRE
Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company
23 May 2016 //
BIOSPACE
Struggling XenoPort rumored to consider a sale
22 Jan 2016 //
FIERCE BIOTECH
XenoPort hits reset after a psoriasis setback…
02 Oct 2015 //
FIERCE BIOTECH
Xenoport to seek partner to develop drug; CEO steps down
01 Oct 2015 //
REUTERS
XenoPort plunges as investors sour fast on `positive` psoriasis data
15 Sep 2015 //
FIERCE BIOTECH